Q1 2024 Voyager Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to Voyager Therapeutics First Quarter 2024 Financial Results Conference Call. (Operator Instructions) Please note that today's conference is being recorded. A replay of today's call will be available on the Investors section of the company's website approximately 2 hours after completion of this call.
I would now like to turn the call over to Trista Morrison, Chief Corporate Affairs Officer.
Thank you, and good afternoon. We issued our first quarter 2024 financial results press release this afternoon. The press release and 10-Q are available on our website. Joining me on today's call are Dr. Al Sandrock, our Chief Executive Officer; Dr. Toby Ferguson, our Chief Medical Officer; and Dr. Todd Carter, our Chief Scientific Officer. We will also be joined for the Q&A portion of the call by our Chief Operating Officer and Principal Financial Officer, Robin Swartz.
Before we get started, I would like to remind
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |